1/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)

NIH RePORTER · NIH · UH3 · $2,887,088 · view on reporter.nih.gov ↗

Key facts

NIH application ID
10165800
Project number
5UH3HL143192-03
Recipient
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
Principal Investigator
Mark T Gladwin
Activity code
UH3
Funding institute
NIH
Fiscal year
2021
Award amount
$2,887,088
Award type
5
Project period
2019-05-15 → 2026-04-30